Phathom Pharmaceuticals (PHAT) Return on Equity [ROE] (2019 - 2022)
Phathom Pharmaceuticals (PHAT) posted Return on Equity [ROE] of -1043.98% for Q2 2022, down 936.56 percentage points from -107.41% a year earlier and down 776.00 percentage points from the prior quarter.
Powered by 
Analysis
Phathom Pharmaceuticals (PHAT) Return on Equity [ROE] (2019 - 2022) Analysis & Trends
For FY2021, Phathom Pharmaceuticals' Return on Equity [ROE] came in at -106.47%, down 45.29 percentage points from FY2020.
- In prior years, Phathom Pharmaceuticals' Return on Equity [ROE] was -61.18% in FY2020 (+35.26 pp) and -96.44% in FY2019.
- The Q2 2022 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q4 2019.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last six quarters, with an average year-over-year change of -167.81 percentage points over the last seven quarters.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -267.98% (Q1 2022), -161.50% (Q4 2021) and -135.59% (Q3 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Phathom Pharmaceuticals | 554.08 Mn | -85.87 Mn | 59.18 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | -1,043.98% |
| Mar 31, 2022 | -267.98% |
| Dec 31, 2021 | -161.50% |
| Sep 30, 2021 | -135.59% |
| Jun 30, 2021 | -107.41% |
| Mar 31, 2021 | -80.18% |
| Dec 31, 2020 | -73.66% |
| Sep 30, 2020 | -53.14% |
| Jun 30, 2020 | -32.91% |
| Mar 31, 2020 | -58.77% |
| Dec 31, 2019 | -289.57% |
API Access
Phathom Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PHAT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PHAT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PHAT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();